The study demonstrates that apoA-I binds to HDL via a two-step process involving the N-terminal helix bundle domain, with a low-affinity interaction for a labile pool of apoA-I molecules.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications for lipid therapy; hypothesis-generating for apoA-I/HDL dynamics in humans.
Lund‐Katz et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: